This inventor holds 2 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Deciphera Pharmaceuticals, LLC, Saint Louis University. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: The Innovations of Timothy Caldwell
Introduction
Timothy Caldwell is an accomplished inventor based in Lawrence, Kansas. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds that target specific biological processes.
Latest Patents
Caldwell holds a patent for "Heteroarylaminopyrimidine Amide Autophagy Inhibitors and Methods of Use Thereof." This patent represents a breakthrough in the understanding and application of autophagy inhibitors, which have potential therapeutic uses in various diseases.
Career Highlights
Caldwell is currently employed at Deciphera Pharmaceuticals, LLC, where he continues to advance his research and development efforts. His work focuses on creating novel therapeutic agents that can improve patient outcomes.
Collaborations
Caldwell collaborates with talented colleagues, including Daniel L. Flynn and Yu Mi Ahn, who contribute to the innovative environment at Deciphera Pharmaceuticals.
Conclusion
Timothy Caldwell's contributions to the field of pharmaceuticals through his patent and collaborative efforts highlight his role as a key innovator in the industry. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile